Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire Health2Sync Completes an Oversubscribed Round of US$20 Million to Fuel Market Expansion and Prepares for Public Listing
Media-OutReach Newswire LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
Media-OutReach Newswire GangaGen Secures additional US$7.9 Million from CARB-X for Pre-clinical Development of Novel Klebicins Targeting Nosocomial Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae
Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
Media-OutReach Newswire Global VC investment falls to lowest level in nearly seven years as number of US$1 billion+ deals falters, according to KPMG Private Enterprise’s Venture Pulse report